ArticleFrontiers in immunology2025

Olverembatinib (HQP1351)-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in blast phase: results from a real-world study.

Ziyu Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.